Bellabeat, Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Bellabeat, Inc. - overview

Established

2014

Location

San Francisco, CA, US

Primary Industry

Medical Devices & Equipment

About

Bellabeat, Inc. is a US-based company dedicated to enhancing women's health and wellness through innovative technology. Its products empower women to track their health and wellness journeys effectively. Founded in 2014 and headquartered in San Francisco, US, Bellabeat, Inc.


specializes in women's health technology. The company has successfully raised USD 14. 205 mn in funding, led by AOL Ventures during its most recent round on May 24, 2018. The founder, Urška Sršen, is known for her commitment to women's technological needs and has successfully navigated the firm through multiple deals in its growth trajectory.


Bellabeat is a pioneering company in the fem-tech sector, primarily focused on women's health and wellness. The company's flagship product, IVY+, is a smart wearable health tracker designed exclusively for women, which assists in monitoring menstrual cycles, pregnancy, and postpartum stages. This device measures various biometric parameters, such as temperature, to provide insights into hormonal fluctuations throughout the menstrual cycle. Alongside IVY+, Bellabeat offers additional digital health solutions, including the Bellabeat Coach, which delivers personalized wellness programs that encompass workouts, nutrition, and mindfulness tailored to each user's cycle stage.


The company targets a diverse consumer base across multiple geographical markets, including North America, Europe, and Asia, catering primarily to women who are health-conscious and looking to optimize their wellness journeys. Bellabeat operates on a subscription-based revenue model alongside direct-to-consumer sales for its products. Customers can choose between various membership plans for access to premium features, with options including a yearly membership at USD 34. 20 and a monthly membership priced at USD 6.


40. Additionally, the company sells its IVY+ tracker and other health-related accessories directly through its online platform, enhancing engagement with its user base. This transactional structure allows Bellabeat to generate recurring revenue while also capitalizing on one-time sales for its product offerings. By combining subscription services with direct sales, Bellabeat effectively addresses the ongoing wellness needs of its clients, ensuring sustained engagement through personalized health advice and tracking capabilities.


Bellabeat plans to leverage the USD 14. 2 million raised in May 2018 to support its growth and expansion strategies. There are upcoming launches of innovative products designed to further assist women in their health journeys, although specific release dates have not been disclosed. The company is also targeting expansion into new markets, with an emphasis on increasing its presence in Europe and Asia by the end of 2023.


Current Investors

Beehive Holdings, Fiftyfive Capital, AOL Ventures

Primary Industry

Medical Devices & Equipment

Sub Industries

Accessories, Healthcare IT, Monitoring Equipment

Website

www.bellabeat.com/

Verticals

E-commerce, HealthTech, Manufacturing, Mobile Apps, Wearables & Quantified Self

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.